Table 5. Differential leukocyte counts and numbers of cells infiltrated into gelatin sponge in mice with per oral administration of oxykine, gliadin or saline.
|
Percentage of differential leukocytes per gelatin sponge-infiltrated cells
|
|||||||
|---|---|---|---|---|---|---|---|
| Treatmenta | No. of mice examined | Total no. of gelatin sponge-infiltrated cells (× 105) | Mø/MO | PMN | LC | EOS | Others |
| Saline | 5 | 15.6±3.1 | 12.1±6.3 | 53.6±7.4 | 28.0±2.8 | 1.6±0.5 | 3.1±2.4 |
| Gliadin | 6 | 19.3±5.8 | 9.9±2.0 | 49.7±6.0 | 26.8±2.7 | 1.6±1.5 | 5.0±0.8 |
| Melon SOD | 6 | 19.0±5.8 | 13.1±4.2 | 50.6±3.1 | 30.7±2.9 | 1.4±1.8 | 4.8±3.7 |
| Oxykine | 6 | 18.4±2.7 | 8.6±4.2 | 53.5±5.4 | 30.8±2.9 | 1.6±1.1 | 4.5±2.3 |
Mø/MO, macrophages/monocytes; PMN, polymorphonuclear neutrophils; LC, lymphocytes; EOS, eosinophils.
a
A piece of gelatine sponge was implanted into the subcutaneous space of normal mice to which oxykine, gliadin or melon-SOD had been administered orally (10 mg kg−1) once daily for 5 days.